Brolucizumab (Beovu)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Brolucizumab (Beovu), covering 2025-01-13 to 2025-01-27. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular Degeneration [Phase 4]